Alexandre Petit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandre Petit has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
A. Delaune
1 shared publication- Anthony Falluel-Morel
University Rouen Normandie, INSERM U1245, Team Epigenetics and Pathophysiology of Neurodevelopmental Disorders, 76183 Rouen, France
1 shared publication - Caroline Gest
Laboratory MERCI (EA 3829), Faculty of Medicine and Pharmacy, CHU Rouen, Rouen, France
1 shared publication - Catherine Buquet
Laboratoire MERCI - EA3829, Faculté de Médecine et de Pharmacie, Université de Rouen, Rouen, France
1 shared publication - Chaoquan Hu
Department of Surgery Affiliated Hospital GuiZhou Medical University Guiyang China
1 shared publication - Charlène Dulong
DIFEMA, Merci (EA 3829), Faculté de Médecine et de Pharmacie, Université de Rouen, F-76183 Rouen, France
1 shared publication
Latest Publications
- 1 November 2013
- Published by Elsevier in Pharmacological Research
- Vol. 77, 11-21
Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells
- 1 November 2013
- Published by Elsevier in Pharmacological Research
- Vol. 77, 11-21
Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells
- Open Access
- 6 February 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 63
Rac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines
Rho GTPases are involved in cellular functions relevant to cancer. The roles of RhoA and Rac1 have already been established. However, the role of Rac3 in cancer aggressiveness is less well understood.
- 6 February 2013
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 63
Open AccessRac3 induces a molecular pathway triggering breast cancer cell aggressiveness: differences in MDA-MB-231 and MCF-7 breast cancer cell lines
Rho GTPases are involved in cellular functions relevant to cancer. The roles of RhoA and Rac1 have already been established. However, the role of Rac3 in cancer aggressiveness is less well understood.